Novel chemotherapeutic drugs are needed to improve tuberculosis (TB) control, especially in the developing world. Given the magnitude of the problem and the resources available in countries that have the highest burden of disease, the present standards of care for the treatment of drug‐susceptible TB, drug‐resistant TB, TB/human immunodeficiency virus (HIV) coinfection, and latent TB infection are all unsatisfactory. Because no truly novel compounds for the treatment of TB have been discovered in the past 40 years, the recent enhanced activity in the research and development of new TB drugs is extremely encouraging. Seven compounds are presently in clinical development specifically for the treatment of TB. Other known antibiotic compound families are being investigated preclinically, in an attempt to identify new antimicrobial drugs with specific antituberculous activity. In addition, novel targets have been identified and are the subject of efforts to validate their potential usefulness in the treatment of TB.
Cited by
Donald E. Low. (2009)
Editorial Commentary: Fluoroquinolones for Treatment of Community‐Acquired Pneumonia and Tuberculosis: Putting the Risk of Resistance into Perspective.
Clinical Infectious Diseases 48:10, 1361-3
Online publication date: 15-May-2009.
Alejandro Speck Planche, Marcus Tulius Scotti, América García López, Vicente Paulo Emerenciano, Enrique Molina Pérez, Eugenio Uriarte. (2009) Design of novel antituberculosis compounds using graph-theoretical and substructural approaches.
Molecular Diversity Online publication date: 2-May-2009.
CrossRef Palaniappan Senthilkumar, Murugesan Dinakaran, Yogesh Chandraseakaran, Perumal Yogeeswari, Dharmarajan Sriram. (2009) Synthesis and
in-vitro
Antimycobacterial Evaluation of 1-(Cyclopropyl/2,4-difluorophenyl/
tert-
butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
Archiv der Pharmazie 342:2, 100-112
Online publication date: 1-Mar-2009.
CrossRef Jerrold J. Ellner. (2009) The Emergence of Extensively Drug-Resistant Tuberculosis: A Global Health Crisis Requiring New Interventions: Part II: Scientific Advances that May Provide Solutions.
Clinical and Translational Science 2:1, 80-84
Online publication date: 1-Mar-2009.
CrossRef Christopher Dye. (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.
Nature Reviews Microbiology 7:1, 81-87
Online publication date: 1-Feb-2009.
CrossRef Jerrold J. Ellner. (2009) The Emergence of Extensively Drug-Resistant Tuberculosis: A Global Health Crisis Requiring New Interventions: Part II: Scientific Advances that May Provide Solutions.
Clinical and Translational Science Online publication date: 1-Feb-2009.
CrossRef Andrea T Cruz, Jeffrey R Starke. (2009) Treatment of tuberculosis in children.
Expert Review of Anti-infective Therapy 6:6, 939-957
Online publication date: 1-Jan-2009.
CrossRef Edward D Chan, Michael D Iseman. (2009) Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
Current Opinion in Infectious Diseases 21:6, 587-595
Online publication date: 1-Jan-2009.
CrossRef Ritu Banerjee, Gisela F Schecter, Jennifer Flood, Travis C Porco. (2008) Extensively drug-resistant tuberculosis: new strains, new challenges.
Expert Review of Anti-infective Therapy 6:5, 713-724
Online publication date: 1-Nov-2008.
CrossRef Claudia Wallrauch, Till Bärnighausen, Tom Heller, Catherine Houlihan, Marie-Louise Newell. (2008) The white and the three-letter plague: integration of TB and HIV care in sub-Saharan Africa.
Future HIV Therapy 2:5, 437-451
Online publication date: 1-Oct-2008.
CrossRef Cheuk-Ming TAM. (2008) Development of new antituberculosis drugs: Its relevance worldwide and in the Asia-Pacific region.
Respirology 13, S125-S131
Online publication date: 1-Oct-2008.
CrossRef Haruaki Tomioka, Yutaka Tatano, Ko Yasumoto, Toshiaki Shimizu. (2008) Recent advances in antituberculous drug development and novel drug targets.
Expert Review of Respiratory Medicine 2:4, 455-471
Online publication date: 1-Sep-2008.
CrossRef J. G. Hurdle, R. B. Lee, N. R. Budha, E. I. Carson, J. Qi, M. S. Scherman, S. H. Cho, M. R. McNeil, A. J. Lenaerts, S. G. Franzblau, B. Meibohm, R. E. Lee. (2008) A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
Journal of Antimicrobial Chemotherapy 62:5, 1037-1045
Online publication date: 18-Aug-2008.
CrossRef Srinivasa P.S. Rao, Luis Camacho, Bee Huat Tan, Calvin Boon, David G. Russel, Thomas Dick, Kevin Pethe. (2008) Recombinase-based reporter system and antisense technology to study gene expression and essentiality in hypoxic nonreplicating mycobacteria.
FEMS Microbiology Letters 284:1, 68-75
Online publication date: 1-Aug-2008.
CrossRef María S Sánchez, James O Lloyd-Smith, Travis C Porco, Brian G Williams, Martien W Borgdorff, John Mansoer, Joshua A Salomon, Wayne M Getz. (2008) Impact of HIV on novel therapies for tuberculosis control.
AIDS 22:8, 963-972
Online publication date: 1-Jun-2008.
CrossRef Marta Martins, Miguel Viveiros, Leonard Amaral. (2008) The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics.
Future Microbiology 3:2, 135-144
Online publication date: 1-May-2008.
CrossRef James C. Sacchettini, Eric J. Rubin, Joel S. Freundlich. (2008) Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
Nature Reviews Microbiology 6:1, 41-52
Online publication date: 1-Feb-2008.
CrossRef Stephen D Lawn, David J Edwards, Robin Wood. (2007) Concurrent drug therapy for tuberculosis and HIV infection in resource-limited settings: present status and future prospects.
Future HIV Therapy 1:4, 387-398
Online publication date: 1-Dec-2007.
CrossRef Alberto Matteelli, Giovanni Battista Migliori, Daniela Cirillo, Rosella Centis, Enrico Girard, Mario Raviglione. (2007) Multidrug-resistant and extensively drug-resistant
Mycobacterium tuberculosis: epidemiology and control.
Expert Review of Anti-infective Therapy 5:5, 857-871
Online publication date: 1-Nov-2007.
CrossRef John G. Bartlett. (2007) Tuberculosis and HIV Infection: Partners in Human Tragedy.
The Journal of Infectious Diseases 196:s1, S124-S125
Online publication date: 1-Jul-2007.
Gerald Friedland, Gavin J. Churchyard, and Edward Nardell. (2007) Introduction: Tuberculosis and HIV Coinfection: Current State of Knowledge and Research Priorities.
The Journal of Infectious Diseases 196:s1, S1-S3
Online publication date: 1-Jul-2007.